Ningxia Zhongke Biotechnology Co (SHSE:600165) Minority Interest: ¥128.15 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600165 Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
52 GF Score
Price ¥3.14
GF Value ¥2.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ningxia Zhongke Biotechnology Co Minority Interest?

Ningxia Zhongke Biotechnology Co SHSE:600165 -1.26% 52 Minority Interest is ¥128.15 Mil as of Jun. 2026. GuruFocus rates SHSE:600165 with a GF Score™ of 52/100 and a GF Value™ of ¥2.35 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Ningxia Zhongke Biotechnology Co's minority interest for the quarter that ended in Jun. 2026 was ¥128.15 Mil.

Ningxia Zhongke Biotechnology Co Minority Interest Historical Data

* Premium members only.

The historical data trend for Ningxia Zhongke Biotechnology Co's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningxia Zhongke Biotechnology Co Minority Interest Chart

Ningxia Zhongke Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 293.40 257.05 206.50 168.37 128.07

Ningxia Zhongke Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.81 137.67 128.07 128.58 128.15
SHSE:600165
52GF Score
Ningxia Zhongke Biotechnology Co Ltd SHSE:600165
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningxia Zhongke Biotechnology Co Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of ¥128.15 Mil mean?
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a Minority Interest of ¥128.15 Mil as of Jun. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Ningxia Zhongke Biotechnology Co.
Is Ningxia Zhongke Biotechnology Co's Minority Interest too high?
Ningxia Zhongke Biotechnology Co's current Minority Interest is ¥128.15 Mil. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's Minority Interest compare to LIN and SHW?
Ningxia Zhongke Biotechnology Co's Minority Interest of ¥128.15 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Chemicals company?
A good Minority Interest depends on the Chemicals industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Ningxia Zhongke Biotechnology Co. Ningxia Zhongke Biotechnology Co's current Minority Interest is ¥128.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.35, compared to a current price of ¥3.14 — trading 33.6% above its estimated fair value. The current Minority Interest is ¥128.15 Mil. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current Minority Interest is ¥128.15 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?

Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be overvalued. The current stock price of ¥3.14 is trading 33.6% above its estimated GF Value™ of ¥2.35. GuruFocus considers Ningxia Zhongke Biotechnology Co to be Significantly Overvalued.

Key valuation signals for SHSE:600165:

  • Minority Interest: ¥128.15 Mil
  • GF Value™: ¥2.35 vs. price of ¥3.14 (33.6% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningxia Zhongke Biotechnology Co Business Description

Address Hebin Street, Ningxia Hui Autonomous Region, Huinong District, Shizuishan, CHN, 750002
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
52GF Score

Get the complete analysis for SHSE:600165

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.14
Price
¥2.35
GF Value